Literature DB >> 16916257

Clinical applications of plasma Epstein-Barr virus DNA analysis and protocols for the quantitative analysis of the size of circulating Epstein-Barr virus DNA.

K C Allen Chan1, Y M Dennis Lo.   

Abstract

Nasopharyngeal carcinoma (NPC) is one of the most common cancers in Southern China. Epstein-Barr virus (EBV) infection is an important etiological factor of NPC. The fact that EBV genome is present in almost all NPC tissues renders it an ideal tumor marker for NPC. To date, quantitative analysis of plasma EBV DNA has been shown to be clinically useful for the detection, monitoring, and prognostication of NPC. In addition, the molecular nature of circulating EBV DNA has recently been identified as that of free DNA fragments; it is not contained inside intact virions. By quantitative size analysis, it is further demonstrated that more than 80% of these DNA fragments are less than 180 bp in size. In this chapter, the clinical applications of plasma EBV DNA analysis and the protocols for the quantitative analysis of the size of circulating EBV DNA will be discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16916257     DOI: 10.1385/1-59745-074-X:111

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

Review 1.  The Epstein Barr virus DNA levels as a tumor marker in EBV-associated cancers.

Authors:  Paolo De Paoli; Chiara Pratesi; Maria Teresa Bortolin
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-25       Impact factor: 4.553

Review 2.  Laboratory assays for Epstein-Barr virus-related disease.

Authors:  Margaret L Gulley; Weihua Tang
Journal:  J Mol Diagn       Date:  2008-06-13       Impact factor: 5.568

Review 3.  Nasopharyngeal carcinoma: molecular biomarker discovery and progress.

Authors:  William Chi-Shing Cho
Journal:  Mol Cancer       Date:  2007-01-02       Impact factor: 27.401

4.  Association of Epstein-Barr virus infection with peripheral immune parameters and clinical outcome in advanced nasopharyngeal carcinoma.

Authors:  Dan Tao; Ningning Zhang; Qingqing Huang; Chuang Ge; Qicheng Li; Shujie Li; Kegui Weng; Qishuai Guo; Jiangdong Sui; Can Wang; Xin Zhang; Ying Wang
Journal:  Sci Rep       Date:  2020-12-15       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.